http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3751404-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd5a5908c54e6b4ca24053f2900e626e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-14
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-14
filingDate 1971-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1973-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e2326caa072386adbe4935344a4a009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d4a7c31082742b54e542bdc2bbfd327
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e57d020e023f9ed386dc99163fc06821
publicationDate 1973-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-3751404-A
titleOfInvention L-prolyl-l-arginyl-l-volyl-l-tyrosyl-l-volyl-l-histidyl-l-prolyl-glycine
abstract NOVEL HEPTA- AND OCTAPEPTIDES OF THE FORMULA: 2-(R1-CO-),1-(NH2-C(=NH)-NH-(CH2)3-CH(-NH-R)-CO-NH-CH(- CH(-CH3)2)-CO-NH-CH(-CH2-(1,4-PHENYLENE)-OH)-CO-R2-NH- CH(-CH2-C<(-NH-CH=N-CH2-))-CO-)PYRROLIDINE WHEREIN R IS HYDROGEN, SUCCINYL, L-ASPARTYL, SARCOSYL, LSERYL, SUCCINAMYL, L-PROLYL, GLYCYL, OR D- OR L-ASPARAGINYL; R1 IS AN L-ALANINE, L- OR D-LEUCINE, GLYCINE, LISOLEUCINE OR B-ALANINE RESIDUE; AND R2 IS L-VALYL, OR LALANYL UPON INTRAVENOUS INFUSION TO ANIMALS INHIBIT BLOOD PRESSURE RESPONSE TO ANGIOTENSIN AMIDE.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4250086-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9611293-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5459077-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3907762-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015179349-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9518086-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4672054-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9534017-B2
priorityDate 1971-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23668817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67540
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415737128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450852399
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22056973
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70275222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456061589
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10236
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71080
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450374235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558132
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10351092
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413982747
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454283314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750

Total number of triples: 55.